TRANSKRIPT – Patent clearance penalises inventors and destroys the scope for venture capital: The COVID-19 pandemic may have peaked, but the debate on seeking suspension of patent protection for COVID-19 vaccines is no less intense. After many months of discussion, the WTO has recently announced that it has reached a first agreement on the way to seeking a suspension of patent protection for COVID-19 vaccines. Rainer Westermann and Sascha Berger of the Life Sciences Acceleration Alliance e.V. explain the problem. Read more.